Notice of Annual General Meeting of Shareholders Tallinn,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Notice of Annual General Meeting of Shareholders

Tallinn, Estonia, 2014-05-27 12:45 CEST (GLOBE NEWSWIRE) --  

Dear shareholder of AS Ekspress Grupp 

Notice is hereby given that the Management Board of AS Ekspress Grupp (registry code 10004677, official address Narva mnt 11E, 10151 Tallinn) convenes the Annual General Meeting of Shareholders, which will be held on 20 June 2014 at 12:00 p.m at the seat of AS Ekspress Grupp, in the city of Tallinn, Narva mnt 11E, 6th floor.   

The registration of participants in the Meeting will commence at 11:30 a.m. at the location of the Meeting.

Pursuant to the Decision of the Supervisory Board of AS Ekspress Grupp, the Agenda of the Annual General Meeting of Shareholders shall be as follows: 

  1. Approval of the Annual Report for the Financial Year 1 January 2013 - 31 December 2013
  2. Approval of the 2013 Profit Distribution Proposal
  3. Removal of Members from the Supervisory Board
  4. Election of new Members of the Supervisory Board
  5. Extension of the authority of Members of the Supervisory Board
  6. Appointment of the auditor and establishment of the procedure of payment

The Supervisory Board and the Management Board of AS Ekspress Grupp present the following proposals to the shareholders regarding the agenda items:  

  1. Approval of the Annual Report for the Financial Year 1 January 2013 - 31 December 2013.

To approve the Annual Report for the Financial Year 1 January 2013 - 31 December 2013 of AS Ekspress Grupp.

  1. Approval of the 2013 Profit Distribution Proposal presented

To approve the Profit Distribution Proposal, according to which the legal reserve will be increased by 54 thousand Euros from the 2013 net profit, which is 1081 thousand Euros, dividends will be paid to the shareholders 1 (one) euro cent per share and 729 thousand Euros will be allocated to the retained earnings of the previous periods.    

  1. Removal of Members from the Supervisory Board

To remove the current Members of the Supervisory Board Ville Jehe (personal code 36910010325) and Aavo Kokk (personal code 36410042742) from Supervisory Board.

  1. Election of new Members of the Supervisory Board

to elect a new Member of the Supervisory Board Indrek Kasela (personal code 37112100291) (consent annexed).

  1. Extention of the authority of Members of the Supervisory Board

To extend the authority of Kari Sakari Salonen (date of birth 11.02.1960), Harri Helmer Rochier (date of birth 11.02.1957), Viktor Mahhov (personal code 36712140214) and Hans Luik (personal code 36103200263) as the Members of the Supervisory Board up to 20 June, 2019.

  1. Appointment of the auditor and establishment of the procedure of payment

To appoint the audit firm AS Deloitte Audit Eesti (registry code 10687819) to perform the audit of AS Ekspress Grupp for the financial years 1 January 2014 - 31 December 2016. The auditing services shall be paid for on the basis of the contract to be signed with the audit firm.

The circle of shareholders entitled to attend the Annual General Meeting will be determined 7 days prior to the General Meeting, i.e. as at 23:59 on 13 June 2014.

All documents concerning the Annual General Meeting of the Shareholders of AS Ekspress Grupp, including draft resolutions, the 2013 Annual Report of AS Ekspress Grupp, the auditor’s report, the Profit Distribution Proposal, and the report of the Supervisory Board are available on the homepage of AS Ekspress Grupp at www.egrupp.ee , as well as at the seat of AS Ekspress Grupp, Narva mnt 11E, Tallinn, 6th floor, on business days from 10:00 to 16:00 starting from the date of notification of the Annual General Meeting until the date of the Annual General Meeting (inclusive).

At the General Meeting, the shareholders are entitled to receive information on the activities of AS Ekspress Grupp from the Management Board. If the Management Board of AS Ekspress Grupp refuses to provide information, the shareholders may demand that the General Meeting decide on the legitimacy of their demand, or submit, within two weeks, an application to court in proceedings on petition to require the Management Board to provide the information. 

Shareholders whose shares represent at least 1/20 of the share capital are entitled to present a draft resolution on each agenda item to AS Ekspress Grupp at least 3 days prior to the General Meeting, i.e. until 17 June 2014, by submitting it in writing to AS Ekspress Grupp, Narva mnt 11E, Tallinn 10151. 

Shareholders whose shares represent at least 1/20 of the share capital are entitled to request the inclusion of additional items in the agenda of the General Meeting of AS Ekspress Grupp, provided that the request is submitted 15 days prior to the General Meeting at the latest, i.e. until 5 June 2014, by submitting it in writing to AS Ekspress Grupp, Narva mnt 11E, Tallinn 10151. 

As at 26 May 2014, the share capital of AS Ekspress Grupp is 17 878 104.60 Euros. The total number of shares is 29 796 841, with each share granting one vote.  

For the registration of participants in the Annual General Meeting of Shareholders, we kindly ask: 

shareholders who are natural persons to present an identity document (e.g. passport or ID card) and representatives of shareholders who are natural persons to present an identity document and a written document certifying their authorisation; 

representatives of shareholders who are legal persons to present an extract (or other such document) from the relevant (commercial) register where the legal person is registered (issued no more than 7 days prior to presenting), and the identity document of the representative. In the case of legal persons registered in a foreign country, the extract from the register must be legalised or certified by an apostil, unless stipulated otherwise in international agreements. Transactional representatives of shareholders who are legal persons must, in addition to the aforementioned documents, present a written document certifying their authorisation. AS Ekspress Grupp may also register a shareholder who is a legal person in a foreign country as a participant in the General Meeting if all the required data concerning the legal person and the representative is contained in a notarised authorisation document issued in the foreign country and the authorisation document is acceptable in Estonia. 

Prior to the General Meeting, shareholders may give notice of the appointment of a representative and the withdrawal by the principal of the authorisation via e-mail to the address andres@egrupp.ee or by delivering the aforementioned document(s) to the seat of AS Ekspress Grupp at Narva mnt 11E, Tallinn, 6th floor (on business days from 10:00 to 16:00) by 16:00 on 19 June 2014 at the latest, using the templates available on the homepage of AS Ekspress Grupp,  www.egrupp.ee . Information on the procedure of appointment and revocation of the authorisation of representatives is available on the homepage of AS Ekspress Grupp, www.egrupp.ee .

 

 

Yours faithfully 

Gunnar Kobin AS Ekspress Grupp Chairman of the Management Board GSM: +372 5188111 E-mail: gunnar@egrupp.ee

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

Isopropanol Market Expected to Reach US$ 6.95 Billion

Updated Category News Views 107

Overview of the Global Isopropanol Market A recent report indicates that the global isopropanol market is set to grow from USD 3.43 billion to USD 6.95 billion, achieving a compound annual growth rate (CAGR) of 7.3% during the forecast period. The Asia Pacific region is expected to dominate the market, capturing a significant share of the revenue. This growth is largely...

Continue Reading
Dynatrace Launches Innovative Observability Solutions for Devs

Updated Category News Views 517

Observability Solutions Tailored for Developers LAS VEGAS-- Dynatrace (NYSE: DT), a leader in AI-powered observability, recently announced the launch of Observability for Developers. This comprehensive suite of solutions aims to equip the developer community with essential runtime insights and troubleshooting capabilities, accelerating the much-needed 'shift-left'...

Continue Reading
Man Group PLC Shares and Position Disclosure Insights

Updated Category News Views 111

Understanding Man Group PLC's Position Disclosure Man Group PLC, a prominent global investment management firm, recently shared a crucial disclosure regarding its interests in securities related to Tritax Big Box REIT plc. This disclosure, in alignment with the UK Takeover Code, is pivotal for transparency and investor awareness. Notably, the firm has reported holding...

Continue Reading
Blackbaud Finalizes Sale of EVERFI to Private Investment Firm

Updated Category News Views 863

Blackbaud Completes Sale of EVERFI Blackbaud, Inc. (NASDAQ: BLKB), a leading software company that prioritizes social impact, has finalized the sale of its EVERFI business. This decision aligns with Blackbaud's ongoing focus on its core services and strategic objectives. Financial Overview and Strategic Review The sale, which was made to a private investment firm, is set...

Continue Reading
Apple's Strategic Move into AI-Enabled Smartphones Revealed

Updated Category News Views 175

Apple's Market Position and Recent Developments Apple (NASDAQ: AAPL) continues to hold its title as the world’s most valuable company, with an impressive market capitalization of about $3.3 trillion. The surge in demand for Apple's flagship device, the iPhone, plays a crucial role in reaching this valuation. However, recent reports indicate a dip in stock prices...

Continue Reading